Sign in

You're signed outSign in or to get full access.

Stuart Huizinga

Director at QUINSTREETQUINSTREET
Board

About Stuart M. Huizinga

Independent director since April 2015; age 63; Audit Committee chair and designated “audit committee financial expert.” Former CFO of multiple technology companies and ex-Arthur Andersen partner; B.S. in Business Administration from San Jose State University; Certified Public Accountant (inactive), California. Tenure on QNST’s board positions him as the primary financial oversight lead, with deep public-company reporting and auditing expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
eHealth, Inc. (NASDAQ: EHTH)SVP & Chief Financial Officer2000–2016 Public company CFO; extensive SEC reporting and finance leadership
Arthur Andersen LLPAudit Partner; worldwide tech practice expert1984–2000 Software/Internet sector audit expertise
Sun Basket, Inc.Chief Financial Officer2017 Consumer/commerce exposure
ACME Technologies, Inc.Chief Financial OfficerAug 2018–Feb 2020 Operating CFO in tech
Apollo Neuroscience, Inc.Chief Financial OfficerDec 2020–May 2023 Health-tech operating finance

External Roles

OrganizationRoleTenureNotes
Movella Holdings Inc.Director; Audit Committee ChairDec 2021–May 2025 Public company; audit committee leadership
Next Insurance, Inc.DirectorOct 2024–Jul 2025 Fintech/insurtech board experience

Board Governance

  • Independence: All directors except the CEO (Valenti) are independent; Audit, Compensation, and Governance committees are wholly independent .
  • Audit Committee: Chair (Huizinga); met 8 times in FY2025; Huizinga designated “audit committee financial expert” per Reg S-K 407(d)(5)(ii) .
  • Board/Committee attendance: Board met 4 times in FY2025; all directors attended ≥75% of Board and committee meetings; no directors attended the 2024 annual meeting (engagement flag) .
CommitteeRoleFY2025 Meetings
AuditChair 8
CompensationNot a member 6 (committee info)
Nominating & Corporate GovernanceNot a member 4 (committee info)

Additional governance signals:

  • Lead Independent Director role exists (James Simons) and Board holds executive sessions enhancing independent oversight .
  • Related party transactions: None >$120,000 since July 1, 2024; standard indemnification agreements only .
  • Insider trading policy prohibits short sales, hedging, margin accounts, and pledging; strengthens alignment and risk controls .

Fixed Compensation

Non-Employee Director Compensation Structure (Policy)

ComponentAmount (Annual)
Board member cash retainer$45,000
Lead Director$15,000
Audit Committee Chair$31,000
Compensation Committee Chair$27,000
Nominating & Governance Chair$14,000
Audit Committee member$10,000
Compensation Committee member$6,000
Nominating & Governance member$3,500

FY2025 Director Compensation – Stuart M. Huizinga

MetricFY2025
Fees Earned or Paid in Cash ($)$76,000
Stock Awards ($)$144,984
Option Awards ($)$0
Total ($)$220,984

Program features:

  • Annual RSU grant sized to $145,000 grant-date value; vests daily over 1 year; directors may elect to defer settlement until departure or change in control .
  • Option alternative: Directors can irrevocably elect options in lieu of cash for the fiscal year; options granted quarterly with fair-value equal to forgone cash .

Performance Compensation

Director Equity Grant Details (FY2025)

Grant DateRSUs (#)Per-Share Grant Date Fair Value ($)Total Grant Date Fair Value ($)Vesting
Oct 31, 20246,904 $21.00 $144,984 Daily over 1 year

Notes:

  • Huizinga also holds deferred RSUs under the director deferral program; see Equity Ownership section below .
  • Director equity is service-vesting (no performance metrics for directors); company performance metrics (Adjusted EBITDA, media margin) apply to executive PSUs/bonuses, not director awards .

Other Directorships & Interlocks

CompanyRolePotential Interlock/Conflict
Movella Holdings Inc.Director; Audit Chair (Dec 2021–May 2025) No QNST-disclosed related party transactions; no compensation committee interlocks reported
Next Insurance, Inc.Director (Oct 2024–Jul 2025) No QNST-disclosed related party transactions

Compensation Committee Interlocks: QNST’s compensation committee (Pauldine, Simons, Smith) reported no officer interlocks or insider participation issues in FY2025 .

Expertise & Qualifications

  • Audit and financial reporting expertise; designated audit committee financial expert .
  • 16+ years as public-company CFO (eHealth) and prior audit partner; deep software/Internet sector knowledge .
  • CPA (inactive), California; B.S. Business Administration, San Jose State University .

Equity Ownership

MetricValue
Shares Beneficially Owned83,894
% of Class≤1% (“*”)
Unvested RSUs at FY2025 End (#)2,304
Deferred RSUs (#)88,029
Shares Outstanding (reference date)55,676,795 (Aug 15, 2025)
Pledging/HedgingProhibited by policy

Ownership alignment:

  • Stock ownership guidelines require non-employee directors to hold shares worth 3x annual cash retainer; as of June 30, 2025, each non-employee director has satisfied the requirement .

Governance Assessment

Positives

  • Strong financial oversight: Audit Chair with audit committee financial expert designation; robust audit committee activity (8 meetings) .
  • Transparent and balanced director pay: Cash retainer plus service-vesting RSUs; option-in-lieu-of-cash available; no tax gross-ups; clawback and anti-hedging/pledging policies in place .
  • Ownership alignment: Director ownership guidelines met; deferred RSUs indicate long-term alignment .
  • No related-party transactions (> $120k) and clean interlocks disclosure; Section 16 compliance issues not noted for Huizinga .

Potential Risks / RED FLAGS

  • Annual meeting engagement: No directors attended the 2024 annual meeting; may signal weaker direct shareholder engagement .
  • Classified board structure: Board remains staggered; can entrench incumbents though Company argues continuity and stability benefits .
  • External board commitments: Multiple external directorships through mid-2025 (Movella, Next Insurance) – monitor for time/attention conflicts; no QNST-related transactions disclosed .

Shareholder Support Signal

  • Say-on-Pay: Approximately 99% approval at 2024 annual meeting; supports Company’s compensation philosophy and governance practices .